S100A1 is a small calcium-binding protein that serves as a critical regulator of cardiac calcium homeostasis and contractile function 1. The protein binds calcium in response to increased intracellular Ca2+ levels, triggering conformational changes that enable interactions with specific target proteins 2. In cardiomyocytes, S100A1 enhances calcium cycling by interacting with key calcium regulatory proteins including SERCA2a, ryanodine receptors, L-type calcium channels, and Na+/Ca2+ exchangers 1. Beyond calcium regulation, S100A1 influences energy balance, myofilament function, and cardiac remodeling processes 1. The protein also localizes to the mitochondrial intermembrane space where it acts as a calcium sensor, regulating mitochondrial bioenergetics and ATP production 3. Clinically, S100A1 shows therapeutic potential for heart failure treatment, as it appears to normalize cardiac function after myocardial infarction and enhance cardiomyocyte functional reserve 1. Gene therapy studies using AAV5-mediated S100A1 delivery have demonstrated cardioprotective effects, preventing left ventricular remodeling and improving ejection fraction in post-infarction models 4. The protein is also expressed in skeletal muscle, with higher levels observed in type 1 muscle fibers 5.